AI Reputation Analysis and Signal Evaluation – OPDIVO (Bristol Myers Squibb)

B
Reputation Level
Medical Devices, Pharma & Biotech
59.3 Avg Reputation

Based on 784 businesses audited.

Brand AI Reputation

Medical Devices, Pharma & Biotech Reputation: OPDIVO (Bristol Myers Squibb) (opdivo.com)

https://opdivo.com 📍 Industry: Medical Devices, Pharma & Biotech
64 Reputation / 100

OPDIVO delivers high-substance clinical information but fails forensically by trapping its proof in a closed-loop system without technical authority markers. It is a scientifically legitimate site that suffers from an ‘authority vacuum’ caused by the complete lack of schema and external verification links. The BS is low, but the ‘Trust Theatre’ is high due to the unverified review counts.

Info Density Power-words vs. Substance ratio.
20 67% Reputation
View evidence →
Semantic Coherence Homepage promise vs. Sub-page reality.
18 90% Reputation
View evidence →
Trust & Proof Verifiable evidence vs. Trust Theatre.
7 35% Reputation
View evidence →
Commodity Fingerprint Detection of industry clichés/templates.
11 73% Reputation
View evidence →
Identity & Authority Expert verifiability & Schema depth.
8 53% Reputation
View evidence →

Medical Devices, Pharma & Biotech Reputation: OPDIVO (Bristol Myers Squibb) (opdivo.com)

Reputation: 64 / 100

The content perfectly aligns with the Pharma & Biotech sector, focusing on immunotherapy (nivolumab) and subcutaneous delivery systems (hyaluronidase-nvhy). The presence of heavy regulatory disclaimers, indication lists, and clinical trial citations (495 people study) confirms its status as a high-compliance pharmaceutical product site.

“The score of 64 is driven primarily by technical authority gaps (Step 5) and the trust theatre flag (Step 3). The high review count without verifiable proof links is the single largest contributor to the BS score. Despite these technical failures, the semantic coherence and unique value proposition keep the score firmly in the 'Low BS' category compared to typical marketing sites.”

Verified Analysis Date: May 31, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result